NO20055888L - Kombinasjonsterapi - Google Patents
KombinasjonsterapiInfo
- Publication number
- NO20055888L NO20055888L NO20055888A NO20055888A NO20055888L NO 20055888 L NO20055888 L NO 20055888L NO 20055888 A NO20055888 A NO 20055888A NO 20055888 A NO20055888 A NO 20055888A NO 20055888 L NO20055888 L NO 20055888L
- Authority
- NO
- Norway
- Prior art keywords
- cpt
- combination
- administration
- vascular
- warm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0314097A GB0314097D0 (en) | 2003-06-18 | 2003-06-18 | Combination therapy |
GB0316181A GB0316181D0 (en) | 2003-07-10 | 2003-07-10 | Combination therapy |
PCT/GB2004/002624 WO2004112801A2 (en) | 2003-06-18 | 2004-06-18 | Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055888L true NO20055888L (no) | 2006-03-16 |
Family
ID=33542667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055888A NO20055888L (no) | 2003-06-18 | 2005-12-12 | Kombinasjonsterapi |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060142239A1 (es) |
EP (1) | EP1658084A2 (es) |
JP (1) | JP2006527753A (es) |
KR (1) | KR20060036058A (es) |
AU (1) | AU2004248968A1 (es) |
BR (1) | BRPI0411567A (es) |
CA (1) | CA2529409A1 (es) |
IL (1) | IL172560A0 (es) |
MX (1) | MXPA05013827A (es) |
NO (1) | NO20055888L (es) |
WO (1) | WO2004112801A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117980A1 (en) * | 2004-06-04 | 2005-12-15 | Pfizer Products Inc. | Method for treating abnormal cell growth |
US20090118340A1 (en) * | 2007-10-12 | 2009-05-07 | Jerzy Gebicki | Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers |
WO2024063569A1 (ko) * | 2022-09-22 | 2024-03-28 | (의) 삼성의료재단 | 종양 혈관 파괴용 약학 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4864021A (en) * | 1984-10-30 | 1989-09-05 | Otsuka Pharmaceutical Co., Ltd. | 5-fluorouracil derivatives |
GB9714249D0 (en) * | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
WO2001074369A1 (en) * | 2000-03-31 | 2001-10-11 | Angiogene Pharmaceuticals Ltd. | Divided dose therapies with vascular damaging activity |
EE200200565A (et) * | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
US6720323B2 (en) * | 2000-07-07 | 2004-04-13 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
AU6623301A (en) * | 2000-07-07 | 2002-01-21 | Angiogene Pharm Ltd | Colchinol derivatives as vascular damaging agents |
CA2482591A1 (en) * | 2002-04-16 | 2003-10-30 | Astrazeneca Ab | Combination therapy for the treatment of cancer |
-
2004
- 2004-06-18 AU AU2004248968A patent/AU2004248968A1/en not_active Abandoned
- 2004-06-18 CA CA002529409A patent/CA2529409A1/en not_active Abandoned
- 2004-06-18 KR KR1020057024244A patent/KR20060036058A/ko not_active Application Discontinuation
- 2004-06-18 EP EP04742979A patent/EP1658084A2/en not_active Withdrawn
- 2004-06-18 MX MXPA05013827A patent/MXPA05013827A/es not_active Application Discontinuation
- 2004-06-18 JP JP2006516444A patent/JP2006527753A/ja active Pending
- 2004-06-18 BR BRPI0411567-8A patent/BRPI0411567A/pt not_active Application Discontinuation
- 2004-06-18 WO PCT/GB2004/002624 patent/WO2004112801A2/en not_active Application Discontinuation
- 2004-06-18 US US10/561,183 patent/US20060142239A1/en not_active Abandoned
-
2005
- 2005-12-12 NO NO20055888A patent/NO20055888L/no not_active Application Discontinuation
- 2005-12-13 IL IL172560A patent/IL172560A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004112801A2 (en) | 2004-12-29 |
IL172560A0 (en) | 2006-04-10 |
JP2006527753A (ja) | 2006-12-07 |
AU2004248968A1 (en) | 2004-12-29 |
WO2004112801A3 (en) | 2005-03-24 |
US20060142239A1 (en) | 2006-06-29 |
MXPA05013827A (es) | 2006-03-13 |
KR20060036058A (ko) | 2006-04-27 |
BRPI0411567A (pt) | 2006-08-01 |
EP1658084A2 (en) | 2006-05-24 |
CA2529409A1 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
DK1551409T3 (da) | Anvendelse af quinazolinderivatet ZD6474 kombineret med gemcitabin og eventuelt ioniserende stråling ved behandling af cancer | |
TR200003879T2 (tr) | İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@ | |
NO20050528L (no) | Kombinasjon av VEGF reseptor tyrosin kinase inhibitorer for behandling av kreft | |
HK1071310A1 (en) | Combination therapy for the treatment of cancer | |
BRPI0418351A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo | |
NO20071428L (no) | Kombinasjon inneholdende ZD6474 og Imatinib | |
CY1105803T1 (el) | Συνθεση πepιλαμβανουσα καμπτοθεκινη και ενα παραγωγο πυριμιδινης για τη θepαπεια καρκινου | |
IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
PT1017675E (pt) | Derivados da camtotecina altamente lipofilos | |
CY1111565T1 (el) | Θεραπεια συνδυασμου του zd6474 με 5-fu και/ή cpt-11 | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
ATE396986T1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
DE60313754D1 (de) | Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin | |
BRPI0413410A (pt) | co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer | |
NO20064753L (no) | Kombinasjonsterapi | |
ATE290388T1 (de) | Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c | |
NO20055888L (no) | Kombinasjonsterapi | |
BR0309996A (pt) | Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias | |
NO20076657L (no) | Kombinasjonsterapi av cancer med AZD2171 og gemcitabin | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
HUP0302629A2 (hu) | Camptotechin és sztilbénszármazékok kombinációját tartalmazó gyógyszerkészítmények rák kezelésére | |
NO20075508L (no) | Stannsoporfinpreparater og administrering | |
TW200500073A (en) | Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |